EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Drug: EF-M2 Sponsors: S.LAB (SOLOWAYS); Activator MAF, LLC; Center for New Medical Technologies, Novosibirsk, Russia Completed
